Tamara Boschert
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer.
Journal: Journal for immunotherapy of cancer
Published: July 30, 2025
Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.
Journal: Cancer cell
Published: July 23, 2025
Computational identification of cross-reactive TCR epitopes with ARDitox.
Journal: Journal of cancer research and clinical oncology
Published: May 27, 2025
Neoadjuvant immune checkpoint inhibition improves protection against hepatic melanoma metastasis.
Journal: Cancer letters
Published: February 19, 2025
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.
Journal: Science advances
Published: February 02, 2024
T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery.
Journal: Science advances
Published: February 02, 2024
Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases.
Journal: Cancer research communications
Published: January 11, 2024
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.
Journal: Neurological research and practice
Published: September 12, 2023
Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy.
Journal: Nature biotechnology
Published: June 13, 2023
A H3K27M-targeted vaccine in adults with diffuse midline glioma.
Journal: Nature medicine
Published: February 23, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026